Viad (VVI) Stock Price, News & Analysis

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Viad in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" VVI shares.
View VVI analyst ratings or view top-rated stocks.

3 Wall Street analysts have issued 1 year price targets for Viad's stock. Their VVI share price targets range from $40.00 to $50.00. On average, they predict the company's stock price to reach $44.33 in the next twelve months. This suggests a possible upside of 29.2% from the stock's current price.
View analysts price targets for VVI or view top-rated stocks among Wall Street analysts.

Viad's stock was trading at $36.20 at the beginning of 2024. Since then, VVI stock has decreased by 5.2% and is now trading at $34.31.
View the best growth stocks for 2024 here.

Viad saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 265,000 shares, an increase of 24.8% from the February 29th total of 212,300 shares. Based on an average daily volume of 81,600 shares, the short-interest ratio is presently 3.2 days. Currently, 1.3% of the shares of the company are sold short.
View Viad's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our VVI earnings forecast.

Viad will be holding an earnings conference call on Thursday, May 2nd at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 929-458-6194 with passcode "959638".

Viad Corp (NYSE:VVI) posted its quarterly earnings results on Thursday, February, 8th. The business services provider reported ($0.79) earnings per share for the quarter, missing analysts' consensus estimates of ($0.70) by $0.09. The business services provider had revenue of $291.68 million for the quarter, compared to analyst estimates of $277.81 million. Viad had a net margin of 0.96% and a trailing twelve-month return on equity of 13.05%.

ETFs with the largest weight of Viad (NYSE:VVI) stock in their portfolio include Invesco S&P SmallCap 600 Pure Growth ETF (RZG).Invesco Russell 2000 Dynamic Multifactor ETF (OMFS).

Viad issued an update on its first quarter 2024 earnings guidance on Thursday, February, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $260.0 million-$284.0 million, compared to the consensus revenue estimate of $268.6 million.

5 employees have rated Viad Chief Executive Officer Steve W. Moster on Glassdoor.com. Steve W. Moster has an approval rating of 80% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Viad investors own include Pfizer (PFE), AbbVie (ABBV), Verizon Communications (VZ), Dynavax Technologies (DVAX), Enbridge (ENB), Procter & Gamble (PG), QUALCOMM (QCOM), Trevena (TRVN), Universal Technical Institute (UTI) and VBI Vaccines (VBIV).

Viad's stock is owned by a number of retail and institutional investors. Top institutional investors include Los Angeles Capital Management LLC (0.15%). Insiders that own company stock include Ellen M Ingersoll, Jeffrey A Stelmach, Joshua Schechter and Steven W Moster.
View institutional ownership trends.

Shares of VVI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.